TORNTPHARM Charts, Analysis and Tips

home > pharma-and-healthcare > pharmaceuticals > torntpharm

Technical Analysis

Technical Strength: 4.9 / 10
Indicator Analysis Signal (0 - 10) Chart
RSI (?) RSI is 48.2946376783. According to RSI analysis, torntpharm is marginally weak. 4 TORNTPHARM RSI Chart
MACD (?) MACD: 9.7351010856 and Signal Line: 19.7070202171. According to MACD analysis, torntpharm is marginally weak. 3.0 TORNTPHARM MACD Chart
Simple Moving Average (?) According to simple moving average analysis, torntpharm is facing resistance from it's 20-day simple moving average at 1778.813 and support level is at 1.72e+03. 8 TORNTPHARM Simple Moving Average Chart
Exponential Moving Average (?) According to exponential moving average analysis, torntpharm is facing resistance from it's 20-day exponential moving average at 1761.839 and support level is at 1.73e+03. 8.0 TORNTPHARM Exponential Moving Average Chart
Bollinger Bands (?) %b is 0.188. According to bollinger bands, torntpharm is technically weak. 3 TORNTPHARM Bollinger Bands Chart
Fibonacci Retracement (?) According to fibonacci retracement, price is above all levels. Major support is at 1728.04 and 1695.0. Resistance level is 1835.0. 6.5 TORNTPHARM Fibonacci Retracement Chart
Average True Range (?) ATR: 45 NA TORNTPHARM Average True Range Chart
Average Directional Index (?) ADX is 17.4 which means TORNTPHARM is in a trading range and there is no trend. NA TORNTPHARM Average Directional Index Chart
Note: Technical Analysis updated at 7PM on every trading day.
End-of-Day Share Price - NSE
November 21, 2019
Open Price 1740.0
High Price 1764.1
Low Price 1727.45
Close Price 1738.9
Absolute Change -3.3
Percentage Change -0.189%
Weekly Change -1.84%
Monthly Change 3.49%
Yearly Change 5.88%
52-week high 1962.0
52-week low 1452.0
Corporate Actions
ExDate Purpose
June 13, 2019 DIV-RS 4 PER SH
February 06, 2019 INT DIV - RS 13 PER SH
February 06, 2019 INTERIM DIVIDEND
See all Corporate Actions
Volume Chart
Real time prices can be delayed by 20 minutes. Prices are refreshed from our server automatically after 1 minute. If NSE real time price is not available then BSE real time prices are provided. Volume displayed might not be correct..

Fundamental Analysis

Beta (?)0.406
Confidence in Beta0.456%
Market Capital Rs. 29426.0 Cr
Whenever available, consolidated financial results are used. For details, see here.
Stock Deliverable Quantity and Daily Volatility
Indicator Analysis Signal (0 - Strong Sell, 10 - Strong Buy) Chart
Deliverable Quantity (?) 21 November 2019: Deliverable Quantity:6.95e+04 NA TORNTPHARM Deliverable Quantity Chart
Annualized Daily Volatility (Spot Price) (?) 21 November 2019: Daily Volatility:0.2789 NA TORNTPHARM Annualized Daily Volatility (Spot Price) Chart

Futures & Options Analysis

Indicator Analysis Signal (0 - Strong Sell, 10 - Strong Buy) Chart
PCR (?) 21 November 2019: PCR_OI:0.477 PCR:0.556 NA TORNTPHARM PCR Chart
Option Pain (?) 21 November 2019: Max Pain:1800.0 NA TORNTPHARM Option Pain Chart
Premium (?) 21 November 2019 Premium: 3.15 Futures OI:344000.0 NA TORNTPHARM Premium Chart
Option_MAX_OI (?) 21 November 2019: Price:1738.9 Put with maximum OI:1680.0 Call with maximum OI:1900.0 NA TORNTPHARM Option_MAX_OI Chart

Futures - NSE

Expiry Date Close Price Open Interest Number of Trades No of Contracts Underlying Closing Price
November 28, 2019 1742.05 344000.0 342.0 342.0 1738.9
December 26, 2019 1749.0 23500.0 22.0 22.0 1738.9
January 30, 2020 1740.0 1000.0 0.0 0.0 1738.9

Announcements

August 13, 2018 Shareholders meeting Revised Shareholder Meeting / Postal Ballot-Scrutinizer's Report
April 13, 2018 Disc. under Reg.30 of SEBI (SAST) Reg.2011 Samir Mehta has submitted to the Exchange a copy of disclosure under Regulation 30(1) and 30(2) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations, 2011.
See all Announcements

Board Meetings

Date Meeting Date Purpose
October 14, 2019 October 23, 2019 Financial Results To consider and approve the financial results for the period ended September 30, 2019
July 10, 2019 July 23, 2019 Financial Results To consider and approve the financial results for the period ended Jun 30, 2019
See all Board Meetings

TORNTPHARM is part of...

Index Weightage
NFTYMCAP50 NA

Get Clearnifty's Android App.

Get clearnifty on Google Play
Get clearnifty on Google Play